1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018;68(6):394-424. doi: 10.3322/caac.21492;
2. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Mangioni C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. The Lancet 1997;350(9077):535-540. doi: 10.1016/s0140-6736(97)02250-2;
3. Boyce J, Fruchter RG, Nicastri AD, Ambiavagar P, Reinis MS, Nelson JH. Prognostic factors in stage I carcinoma of the cervix. Gynecologic Oncology 1981;12(2):154-165. doi: 10.1016/0090-8258(81)90145-1;
4. Fuller AF, Elliott N, Kosloff C, Hoskins WJ, Lewis JL. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for Stage IB and IIA carcinoma of the cervix. Gynecologic Oncology 1989;33(1):34-39. doi: 10.1016/0090-8258(89)90598-2;
5. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study. International Journal of Radiation Oncology*Biology*Physics 2006;65(1):169-176. doi: 10.1016/j.ijrobp.2005.10.019;